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Background: Gold nanoparticles (GNPs) are likely to provide an attractive platform for 
combining a variety of biophysicochemical properties into a unified nanodevice with great 
therapeutic potential. In this study we investigated the capabilities of three different natural 
polyphenols, epigallocatechin-3-gallate (EGCG), resveratrol (RSV), and fisetin (FS), to allow 
synergistic chemical reduction of gold salts to GNPs and stabilization in a single-step green pro-
cess. Moreover, antioxidant properties of the nanosystems, as well as preliminary antiproliferative 
activity and apoptotic process investigation of model EGCG-GNPs on stable clones of neuro-
blastoma SH-SY5Y cells expressing CFP-DEVD-YFP reporter, were examined.
Methods: The GNPs were characterized by physicochemical techniques, polyphenol content, 
and in vitro stability. The antioxidant activity of the GNPs was also determined by 2,2-diphenyl-
1-picrylhydrazyl (DPPH) and 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) cation 
(ABTS) radical-scavenging assays. Stable clones of neuronal SH-SY5Y-CFP-DEVD-YFP 
were generated and characterized, and cell viability after treatment with EGCG-GNPs was 
assessed after 72 hours through a 3(4,5-dimethylthiazol-2yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium assay. Activation of the apoptotic pathways was also investigated 
by Western blot analysis.
Results: With a diameter in the size range of 10–25 nm, the obtained nanoparticles (NPs) were 
found to contain 2.71%, 3.23%, and 5.47% of EGCG, RSV, and FS, respectively. Nanoprototypes 
exhibited remarkable in vitro stability in various media, suggesting that NP surface coating 
with phytochemicals prevents aggregation in different simulated physiological conditions. The 
scavenging activities for DPPH and ABTS were highly correlated with EGCG, RSV, and FS 
content. Moreover, high correlation coefficients between the ABTS and DPPH values were found 
for the prepared nanosystems. EGCG-GNPs induce a dose-dependent reduction on SH-SY5Y-
CFP-DEVD-YFP cell viability that is likely to involve the activation of the apoptotic pathways, 
similarly to free EGCG, as suggested by the processing of the CFP-DEVD-YFP reporter.
Conclusion: These results prompted us to propose the ecofriendly synthesized EGCG-, RSV-, 
and FS-based nanogold conjugates as suitable carriers for bioactive polyphenols to be used 
for the treatment of disorders associated with oxidative stress, including neurodegenerative 
disorders, cardiovascular disease, and cancer.
Keywords: gold nanoparticles, epigallocatechin-3-gallate, resveratrol, fisetin, antioxidant 
activity, SH-SY5Y-CFP-DEVD-YFP cells
Introduction
In recent years, the synthesis and biofunctionalization of water-dispersible gold 
nanoparticles (GNPs) have attracted intense interest due to their potential use in biol-
ogy and medicine.1–4 Some of the major biomedical applications of GNPs include gene 
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therapy,5 protein delivery,6 cancer diagnosis,7,8 photothermal 
and photodynamic therapy,1 and delivery of antitumor 
agents.1–4,9
The most commonly used method for the synthesis of 
GNPs is the reduction of chloroauric acid by trisodium 
citrate.10 Other chemical and physical techniques involve 
the use of powerful and highly toxic reducing agents such as 
hydrazine and sodium borohydride, as well as high tempera-
ture and pressure conditions.11 Moreover, the synthesis of the 
GNPs can be performed in the presence of a stabilizer in order 
to modify the surface by physisorption, specific recognition, 
and electrostatic interactions to ensure stability,12,13 which is 
an important determinant for the potential use of gold nano-
conjugated as therapeutic agents.14 In order to minimize or 
eliminate further chemical interventions and to improve the 
sustainability of the process, alternative biosynthetic green 
methods that utilize plant-based phytochemicals for reduction 
of metal ions provide an inherently green approach to nano-
technology, also referred to as “green nanotechnology”.15
Recently, several studies have demonstrated the dual 
role of whole plant extracts and pure compounds isolated 
from plants as effective reducing agents and as stabilizers, 
to provide a robust coating on the biocompatible GNPs.16–20 
The reactive phytochemical species include polyphenols 
such as flavonoids and nonflavonoids, the most abundant 
antioxidants in human diets, usually found in some fruits, 
vegetables, and beverages.21,22
In this study we investigated the capability of three differ-
ent natural polyphenols, epigallocatechin-3-gallate (EGCG), 
resveratrol (RSV), and fisetin (FS), to provide synergistic 
chemical reduction of gold salts to GNPs, as well as stabili-
zation in a single-step green process (Figure 1).
Figure 1 The work plan: from polyphenols to nanogolds. chemical structures of egcg, rsV, and Fs are included.



































single-step green synthesis and characterization of gNPs
These polyphenols, with different chemical structures, 
have been selected because they have received a great deal 
of interest worldwide as potent bioactive substances endowed 
with chemopreventive/therapeutic activities because of their 
anti-invasive and antiproliferative effects in a wide variety 
of tumor cells,23–26 with an increased effectiveness when 
formulated into a variety of nanosystems.27–31
On the other hand, the functionalization of GNPs’ surface 
with these bioactive substances might provide a new useful 
approach as delivery and therapeutic tools, in particular by 
improving the biopharmaceutical properties of these polyphe-
nols, such as their poor bioavailability and stability, as well as 
their resistance to specific/nonspecific metabolic processes.
As far as the chemical structure is concerned, EGCG 
(ie, [-]-epigallocatechin-3-gallate) is a flavonoid constituted 
by a dihydroxybenzopyran scaffold carrying a pyrogallol-
type structure on the B-ring and a galloyl moiety in the D-ring 
(Figure 1). RSV (ie, trans-3,5,4′-trihydroxystilbene) is a 
triphenolic phytoalexin having the trans-stilbene skeleton, 
while FS (ie, 3,3′,4′,7-tetrahydroxyflavone) is a flavone-3-ol 
that bears a catecholic structural unit in the B-ring and the two 
hydroxyl groups located in the C- and A-rings (Figure 1).
To date, few examples of EGCG-conjugated nanogold have 
been reported. In a pioneering work, Nune et al32 investigated 
the role of phytochemicals present in black tea leaves and com-
mercially available catechins to provide GNPs with therapeutic 
potential. More recently, they demonstrated that biocompatible 
radioactive GNPs stabilized by EGCG bind with excellent 
affinity to laminin receptors overexpressed in prostate tumor 
cells, and reduce prostate tumor volumes in vivo.33 Further-
more, Hsieh et al34 reported on the synthesis, characterization, 
antioxidant activity, cytotoxicity in vitro, as well as anticancer 
activity in vivo of EGCG-conjugated nanogold.
The reaction mechanism for the formation of GNPs in 
aqueous solution by polyphenols reduction has been proposed 
in several reports.35–37 Polyphenols such as EGCG demon-
strated to be efficient ligands for metal ions and multiple 
phenolic hydroxyls are able to bind Au3+ ions by forming 
stable chelating rings. As a consequence of complexation, a 
redox reaction occurs, and the chelated Au3+ ions are reduced 
to Au0 atoms in situ, while a part of the phenolic hydroxyls 
is simultaneously oxidized to corresponding quinone. Thus, 
polyphenolic molecules result in being physically attached 
onto the surface of nanogold particles, and the binding of an 
O atom of the polyphenol molecule to the GNPs’ surfaces 
is presumably due to the electron transfer from O atoms 
to Au3+ ions, as confirmed by computational studies.38 On 
the other hand, the high density of free hydroxyl groups, 
especially in EGCG-GNPs, could lead to extensive inter- and 
intramolecular hydrogen bonding, which favors formation 
of unique supramolecular assemblies.
However, so far, the potential of RSV and FS as reducing 
agents for the synthesis of GNPs, as well as on their putative 
effectiveness when attached on the GNPs’ surface, has not 
been explored yet. Therefore, it could also be interesting to 
preliminarily explore the behaviour of GNPs decorated with 
these polyphenols (ie, EGCG, RSV, and FS).
More specifically, we sought to test whether or not the 
intrinsic antioxidant activity displayed by the free compounds 
was retained when they are adsorbed to the nanoparticles 
(NPs) surface. Moreover, we wanted to investigate the ability 
of these engineered capped GNPs in regulating and modulating 
cellular responses, by evaluating their antiproliferative activity 
and induction of apoptosis on stable clones of neuroblastoma 
SH-SY5Y cells expressing CFP-DEVD-YFP reporter.
Herein, we report on “green nanosynthesis” and char-
acterization, in terms of physicochemical properties and 
polyphenols content, of novel prototypes of polyphenol-
capped GNPs (Figure 1) suitable for biomedical finaliza-
tion. In vitro stability of the colloidal suspensions in various 
physiological media was also investigated. Furthermore, the 
capability of obtained GNPs for scavenging free radicals was 
demonstrated in vitro by following the reaction with stable 
2,2-diphenyl-1-picrylhydrazyl (DPPH) and 2,2′-azinobis 
(3-ethylbenzothiazoline-6-sulfonic acid) cation (ABTS) radi-
cals. Finally, cell viability after treatment with an EGCG-GNP 
model was evaluated through a 3(4,5-dimethylthiazol-2yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium 
(MTS) assay, and activation of the apoptotic pathways was 
investigated by Western blot analysis.
Materials and methods
chemicals and reagents





.99.5% purity), DPPH, ABTS, and GNPs (15 nm diam-
eter, stabilized suspension in citrate buffer) were purchased 
from Sigma–Aldrich (Steinheim, Germany). EGCG ($99% 
purity) and RSV ($98% purity) were purchased from Zhe-
jiang Yixin Pharmaceutical Co., Ltd. (Zhejiang, People’s 
Republic of China). FS (.98% purity) was purchased from 
Shaanxi Taiji Huaqing Technology Co., Ltd. (Shaanxi, 
People’s Republic of China).
synthesis of gNPs
The synthesis of GNPs was carried out by modification 
of a method previously reported.32 Aqueous solution of 









O (10 mM, 1.0 mL) and polyphenol (EGCG, 
RSV, or FS) solution (1.0 mM, 5.0 mL) was mixed under 
gentle stirring at room temperature. EGCG was solubilized in 
water, while RSV and FS were solubilized in ethanol:water 
mixture (1:4, v/v). The color of the mixture containing EGCG 
and RSV turned purple–red from pale yellow within a few 
minutes, indicating the formation of GNPs. For the solution 
containing FS the color appeared orange then yellow and 
purple–red after about 10 minutes. The reaction mixture was 
stirred for an additional 30 minutes. The GNPs were collected 
by centrifugation (20,000 rpm, 10 minutes, 15°C) and washed 
three times with water to ensure that no unbound EGCG, 
RSV, or FS molecules remained in the NP dispersion.
characterization
The ultraviolet-visible (UV-vis) absorbance spectrum of 
diluted aqueous NP suspensions was recorded using a 
Cary 3 UV-vis spectrophotometer (Varian Medical Systems, 
Inc., Palo Alto, CA, USA).
The morphology and size of the GNPs were characterized 
by transmission electron microscopy (TEM) (FEI Tecnai 
G12; FEI, Hillsboro, OR, USA). A drop of sample was placed 
on a formvar-coated 400 mesh copper grid, followed by dry-
ing the sample at ambient conditions before it was attached 
to the sample holder on the microscope.
The phase characteristics of the as-prepared prod-
ucts were examined by powder X-ray diffraction (XRD; 
Bruker D8 Advance diffractometer) using Cu Kα radiation 
(λ=1.54056 Å), operating at 40 kV and 40 mA. Results were 
recorded in the 2θ range from 20° to 80° with a scanning step 
of 0.02° per step and 2 seconds per point.
Infrared spectra were collected on a Fourier transform 
infrared (FT-IR) spectrometer (Bruker Optics, Ettlingen, 
Germany) at a resolution of 4 cm-1 in KBr pellets. The 
measurements were performed on EGCG, RSV, and FS raw 
materials as well as on GNPs produced.
Determination of polyphenol content
The polyphenol content was determined by spectrophoto-
metry, using EGCG, RSV, and FS as standard, with some 
modifications of the method described.39,40 Briefly, 0.1 mg of 
the GNPs was transferred to separate tubes containing 0.5 mL 
of a 1/10 dilution of Folin–Ciocalteu’s reagent in water. Then, 
1.0 mL of a sodium carbonate solution (7.5% w/v) was added. 
The tubes were then allowed to stand at 30°C for 30 minutes 
before absorbance at 760 nm was measured. The polyphenol 
content was expressed as EGCG, RSV, and FS equivalents 
in μg/100 μg GNPs. The concentration of polyphenol in 
samples was derived from the standard curve of EGCG, RSV, 
and FS raw materials ranging from 0.1 to 10 μg/mL (EGCG: 
y=0.0563x+0.0101; R2=0.9993; RSV: y=0.0765x+0.0086; 
R2=0.9990; FS: y=0.0649x+0.0104; R2=0.9991) (Figure S1).
In vitro stability
In vitro stability studies of GNPs were performed in differ-
ent media as previously reported.32 Typically, colloidal NP 
solution was added to glass vials containing 1.5 mL of 0.5% 
bovine serum albumin (BSA), 0.5% cysteine, 5.0% sodium 
chloride (NaCl), and phosphate-buffered solution (PBS) 
pH 5, pH 7, and pH 9, respectively, and incubated for 3 hours 
at room temperature. The stability of GNPs was measured by 
monitoring UV absorbance at 30-minute intervals. A negli-
gible change in UV-vis plasmon band confirmed the retention 
of nanoparticulate composition in all mixtures.
antioxidant test: DPPh assay
The capacity of plant materials to catalyze the decomposi-
tion of free radicals can be determined by their ability to 
reduce the concentration of the stable free radical DPPH.41 
The method previously described by Gülçin42 was used 
with slight modifications. Stock solutions of DPPH were 
prepared at 0.1 mmol/L in ethanol and stored at -20°C until 
needed. An appropriate amount of GNPs dispersed in ethanol 
(500 μL) was added to 1.0 mL DPPH solution in a test tube 
to give different final concentrations of NPs (25, 50, 100, 
and 200 μg/mL). The mixture was sonicated for 5 minutes 
and then left to stand in the dark. The supernatant containing 
only DPPH was obtained by centrifuging at 20,000 rpm for 
5 minutes. Nonfunctionalized GNPs commercially available 
were tested as comparison at the same concentration.
The absorption of the supernatant was measured at 517 nm 
against blank samples lacking scavenger using a UV-vis 
spectrophotometer. The decrease in absorbance was deter-
mined at 5-minute intervals up to 30 minutes. The scavenging 























 are absorption of control 
DPPH and sample applied DPPH at 517 nm, respectively.
antioxidant test: aBTs assay
The ABTS radical cation decolorization test is a spectro-
photometric method widely used for the assessment of 
antioxidant activity of various substances. The experiment 
was carried out by adapting a method previously reported.43 




single-step green synthesis and characterization of gNPs
In brief, a mixture containing 99 mL of ABTS solution 
(5.0×10-4 M) and 1.0 mL of sodium persulfate (6.89×10-3 M) 
was stored in the dark at room temperature for 16 hours 
before use. The produced ABTS•+ solution was diluted 
with ethanol to obtain an absorbance of approximately 0.85 
at 734 nm. After the addition of 900 μL of diluted ABTS• 
solution to 100 μL of sample, the absorbance reading was 
taken at 1-minute intervals up to 5 minutes. Nonfunctional-
ized GNPs commercially available were used as comparison. 
A sample blank was run in each assay. All determinations 
were carried out in triplicate after centrifugation at 20,000 
rpm for 1 minute. The percentage radical-scavenging activity 
was calculated as follows:
 




















 is absorbance of a control lacking any radi-
cal scavenger and ABS
Sample
 is absorbance of the remaining 
ABTS•+ in the presence of a scavenger.44
cell culture
Human neuroblastoma SH-SY5Y cells (American Type 
Culture Collection number CRL-2266) were cultured in 
Dulbecco’s Modified Eagle Medium F-12 (DMEM/F12) 
ground (Life Technologies, Carlsbad, CA, USA) in the 
presence of 10% fetal calf serum (Life Technologies) inac-
tivated at 56°C for 30 minutes. The cells are grown in an 
incubator at 37°C in a humidified atmosphere containing 5% 
CO
2
. Stable clones expressing CFP-DEVD-YFP (Addgene 
company code 24537) were obtained by transfecting cells 
with LipofectAMINE LTX and PLUS reagent (Life Tech-
nologies) using 1.5 μg DNA/5–7×105 cells according to the 
manufacturer’s protocol. The different SH-SY5Y clones 
were maintained under selection by 400 μg/mL of G418. 
Individual clones expressing antibiotic resistance were 
picked after 14 days of selection, moved into a 48-well plate, 
and maintained in selective medium until confluence growth. 
Different individual clones were analyzed for CFP-DEVD-
YFP expression upon treatment with the caspase-3 activator 
staurosporine (1 μg/mL).
assessment of cell viability
The viability of control SH-SY5Y-CFP-DEVD-YFP cells 
was calculated after 72 hours through an MTS assay. Cell 
viability was assessed by a colorimetric assay using the 
MTS assay (CellTiter 96 Aqueous One Solution Assay; 
Promega Corporation, Madison, WI, USA), according to 
the manufacturer’s instructions. Absorbance at 490 nm was 
measured in a multilabel counter (Victor X5; Perkin Elmer, 
Waltham, MA, USA).
Immunofluorescence
One×105 cells were grown on a cover-glass for 24 hours and 
treated with staurosporine (1.0 μM) for 2 hours. Cells were 
washed twice with PBS 1X and then fixed with 1 mL of 4% 
paraformaldehyde/PBS 1X for 10 minutes. Before analysis, 
cells were mounted using Mowiol mounting medium45 and 
fluorescence was revealed with a Leica TCS SP5 confocal 
microscope with LAS lite 170 image software.
Western blot analysis
Western blot analysis was performed as previously 
described.46 Briefly, protein content was determined 
using the Bradford protein assay. Equal amounts of pro-
tein extracts were resolved by standard sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis. Samples were 
electroblotted onto Protan nitrocellulose (Schleicher and 
Schuell BioScience GmbH, Dassel, Germany). Membranes 
were incubated with 3% low-fat milk in 1X PBS-Tween 
0.05% solution with rabbit anti-green fluorescent protein 
(anti-GFP; Enzo Life Science, Farmingdale, NY, USA; 
1:1,000 final dilution) or mouse anti-β-actin (Sigma-Aldrich; 
1:1,000 final dilution) for 16 hours at 4°C. Goat antimouse 
immunoglobulin G (IgG) peroxidase-conjugated antibody 
(Millipore Corporation, Billerica, MA, USA; 1:2,500 final 
dilution) or goat antirabbit IgG peroxidase-conjugated anti-
body (Millipore; 1:2,500 final dilution) were used to reveal 
immunocomplexes by enhanced chemiluminescence (Pierce 
Biotechnology, Rockford, IL, USA).
statistical analysis
Data are expressed as the mean ± standard deviation of 
experiments carried out in triplicate. The significance of 
differences was assessed by one-way analysis of variance. 
Individual differences were evaluated using a nonparamet-
ric post hoc test (Tukey’s test) and considered statistically 
significant at P,0.05.
Results and discussion
synthesis and characterization of gNPs
In this study, green reduction of Au3+ to GNPs by bioactive 
polyphenols EGCG, RSV, and FS was performed by simply 
mixing polyphenol and metal gold salt solutions at room 
temperature. The reaction was complete within minutes and 
the formation of EGCG-, RSV-, and FS-capped GNPs could 
be followed by color change from yellow to reddish violet 





(Figure S1), due to excitation of surface plasmon resonance 
(SPR) vibration of GNPs.
In UV-vis absorbance spectra (Figure 2), synthesis of 
GNPs was confirmed by characteristic SPR peak centered 
at 554, 540, and 544 nm for EGCG-, RSV-, and FS-capped 
GNPs, respectively. The significant SPR shift to higher 
wavelengths observed for EGCG-GNPs suggests an increase 
in particle size compared with NP batches prepared using 
RSV and FS.47
The size and shape of the GNPs were investigated with 
TEM. The images reported in Figure 3 show that EGCG-
GNPs (Figure 3A) are in variable shapes. Most of them are 
spherical in nature, followed by occasionally triangular and 
rarely hexagonal.
On the other hand, a more uniform size distribution and 
homogeneous spherical shape of RSV and FS-GNPs were 
Figure 2 Ultraviolet-visible spectra of stable gNPs synthesized by egcg, rsV, and 
Fs polyphenols.
Notes: Wavelength expressed in nm. egcg-gNPs, rsV-gNPs, and Fs-gNPs 
indicate polyphenol-capped nanogold.
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Figure 3 Transmission electron microscopy micrographs of (A) egcg-, (B) rsV-, and (C) Fs-capped gNPs.
Note: Distances expressed in nanometers (nm).
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.




single-step green synthesis and characterization of gNPs
observed (Figure 3B and C, respectively). As reported in 
Table 1, the size of the NPs was in the range of 10–25 nm 
and was influenced by the polyphenol used in the synthetic 
procedure.
These findings suggest that EGCG, RSV, and FS could 
be successfully used as reducing and stabilizing agents to 
produce GNPs with a narrow size distribution. Significant 
differences (P,0.05) were found in mean diameter of 
EGCG-GNPs with respect to FS-GNPs.
The powder XRD patterns (Figure 4) showed that syn-
thesized GNPs were crystalline. The pattern presents four 
distinct diffraction peaks at 38.17, 44.33, 64.70, and 77.70, 
which are assigned to (1 1 1), (2 0 0), (2 2 0), and (3 1 1) 
crystalline plane diffraction peaks of cubic GNPs, respec-
tively, in agreement with the database of the Joint Committee 
on Powder Diffraction Standards (JCPDS No 04-0784). The 
absence of any other crystallographic impurities peaks in 
the XRD spectrum confirmed the high purity of synthesized 
GNPs, in accordance with that reported earlier for similar 
prototypes.48
The average particle size was estimated using the Scherrer 
equation:
 
d k  cos = ( )λ β θ/ /1 2  (3)
where k is the Scherrer constant (0.89), λ is the X-ray wave-
length of Cu Kα1 radiation, β1/2 is the width of the XRD 
peak at half-height, and θ is the Bragg angle.
The average size of the NPs, calculated from the width 
of the diffraction peak, was about 19.49, 12.16, and 9.90 nm 
for EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively, 
which were in line with the results obtained from TEM 
measurements.
To acquire further information about the presence of 
polyphenols coating in the NP surface, FT-IR measurements 
of both free polyphenols and the corresponding gold-capped 
derivatives were assessed.
The analysis of FT-IR spectrum of free compounds and 
corresponding capped GNPs evidenced an overlapping 
behavior between all three couples of samples (Figure 5). In 
particular, the spectra of EGCG and EGCG-GNPs are char-
acterized by the typical C=O ester band at about 1,700 cm-1 
(Figure 5A). Moreover, aromatic double-bond stretching at 
about 1,610 cm-1, aromatic C–C stretching at 1,450 cm-1, 
O–H bending vibration centered at 1,375 cm-1, and C–O 
stretching at 1,210 cm-1 were also detected in both samples. 
Spectra of RSV and RSV-GNPs (Figure 5B) revealed four 
intense bands at about 1,610, 1,590, 1,450, and 1,150 cm-1, 
corresponding to C–C aromatic double-bond stretching, 
C–C olefinic stretching, aromatic C–H stretching, and C–C 
aromatic bending vibration, respectively. Finally, FS and its 
nanogold derivative showed similar pattern signals (Figure 
5C), which are constituted by C=O stretching of the ketone 
functionality located on the chromen-4-one ring (1,725–1,690 
cm-1), C=C stretching (1,605 cm-1), C–C stretching (1,260 
cm-1), and C–OH bending vibration (1,110 cm-1).
Determination of polyphenol content
Since GNPs can be proposed as suitable carriers for the 
delivery of bioactive EGCG, RSV, and FS, as well as for 
other related phytochemicals, it is important to determine the 
amount of polyphenols adsorbed on the NPs’ surface.
To evaluate the EGCG, RSV, and FS content in gold 
nanosystems, the rapid colorimetric Folin–Ciocalteu method, 
frequently used for quantification of total phenolic content in 
natural products, was considered in this study.49 We derived 
the concentration of each polyphenol in NPs from the stan-





















Figure 4 X-ray diffraction pattern of (A) egcg-, (B) rsV-, and (C) Fs-capped gNPs.
Note: Diffraction angle 2θ expressed in degrees.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, 
gold nanoparticles.
Table 1 Mean diameter of egcg-, rsV-, and Fs-capped gNPs
Polyphenol-capped  
GNPs





Notes: Diameter expressed in nanometers (nm). *Significantly different from other 
gNP-polyphenols. egcg-gNPs, rsV-gNPs, and Fs-gNPs indicate polyphenol-
capped nanogold.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, 
gold nanoparticles.





(Figure S2). The percentage of polyphenol content resulted 
as 2.71%, 3.23%, and 5.47% (w/w) for GNPs synthesized 
using EGCG, RSV, and FS, respectively.
In vitro stability
One of the most important aspects to be taken into account 
for various biomedical applications of GNPs is their stability 
in physiological media, in order to prevent aggregation.32 
In fact, it represents a key issue that underlies multiple del-
eterious effects in many therapeutics, including loss of effi-
cacy, altered pharmacokinetics, and induction of unwanted 
immunogenicity.
The stability of polyphenol-capped GNPs was moni-
tored using absorption spectroscopy in 0.5% BSA, 0.5% 
cysteine, and 5.0% NaCl solutions over 3 hours. We have 
also investigated the stability of GNPs in PBS at pH 5, 7, 
and 9.
On the whole, the plasmon wavelengths in all the tested 
GNPs (Figure 6A–C) show minimal shifts of 1–5 nm, con-
firming that the NPs are intact, thus demonstrating good in 
vitro stability in simulated biological fluids. These results 
confirm that EGCG, RSV, and FS are acting in stabiliz-
ing gold nanoparticulate systems from agglomerations in 
solution. It was also observed that at pH 9 all GNPs are 
characterized by a more remarkable (7–12 nm) blue shift 
in SPR band. As previously reported, the shift in SPR can 
be correlated with NPs’ surface charge at different pH.50 In 
alkaline pH, the presence of a high concentration of hydroxyl 
ions on the surface of NPs might maximize their repulsive 
electrostatic and electrosteric interactions, thus reducing 
particles aggregation, as detected by the hypsochromic shift 
of UV-vis peak.48
On the other hand, when colloidal gold solution was 
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Figure 5 Fourier transform infrared spectra of (A) egcg-gNPs, (B) rsV-gNPs, and (C) Fs-gNPs, compared with pure egcg, rsV, and Fs, respectively.
Note: Wavenumber expressed in cm-1.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles.
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slightly shifted red (~7 nm). These results could be attrib-
uted to the possible formations of BSA–colloidal gold 
complex, probably due to the interaction with free thiol 
groups of protein.51
Concerning RSV-GNPs and FS-GNPs, a slight red shift 
(7 and 10 nm, respectively) was also observed when the 
strong electrolyte (ie, NaCl) was added at 5.0% concentra-
tion; the high concentration of ions presumably shielded the 
repulsive electrostatic forces between NPs, allowing them 
to form small aggregates. Considering that in physiological 
conditions the concentration of NaCl corresponds to 0.9% 
(150 mM), all produced GNPs can be considered stable.
antioxidant activity: DPPh assay
Measurement of radical-scavenging activity using discol-
oration of DPPH has been widely used due to its stability, 
simplicity, and reproducibility.42
As shown in Figure 7A, all GNPs scavenged DPPH radi-
cals in a dose-dependent manner and shared a good linear 
correlation between the percentage inhibition of the DPPH 
and the amount of GNPs used (ECGG-GNPs: R2=0.9534; 
RSV-GNPs: R2=0.9295; FS-GNPs: R2=0.9880).
At all tested concentrations, EGCG-GNPs and FS-GNPs 
exhibited a similar DPPH-scavenging activity. Percentage 
inhibition of DPPH ranged from about 16% and 19% at a 
lower concentration (25 μg/mL) to 60% and 66% obtained at 
higher concentration (200 μg/mL) for EGCG-GNPs and FS-
GNPs, respectively. On the contrary, the RSV-GNPs showed 
a significantly lower (P,0.05) free radical-scavenging effect 
when compared with EGCG-GNPs and FS-GNPs, with only 
26% of scavenging activity at 200 μg/mL.
Moreover, the kinetics of DPPH• radicals-scavenging 
activity of all GNPs increased with an increase in the con-
centration, and the decrease in absorbance reached a plateau 
within the 5-minute sampling period, which indicated that the 
reaction had reached completion (data not shown).
antioxidant activity: aBTs assay
The ABTS assay is another commonly used method avail-
















































Figure 6 In vitro stability ultraviolet-visible studies of gNPs capped with (A) egcg, (B) rsV, and (C) Fs in different media.
Notes: Wavelength expressed in nm. egcg-gNPs, rsV-gNPs, and Fs-gNPs indicate polyphenol-capped nanogold.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; BSA, bovine serum albumin; Cys, cysteine; NaCl, sodium chloride.





based on their ability to scavenge the long-life radical cation 
ABTS•+.52
The results reported in Figure 7B show that radical-
scavenging activities of all the GNPs increased linearly with 
increasing concentration, exhibiting their dose-dependent 
nature (EGCG-GNPs: R2=0.9921; RSV-GNPs: R2=0.9924; 
FS-GNPs: R2=0.9993). The antioxidant activity was found 
to be stronger for FS-GNPs, followed by the RSV-GNPs and 
then EGCG-GNPs.
The scavenging percentages range from 6%, 8%, and 15% 
at 25 μg/mL to 46%, 51%, and 55% at higher concentration 
(200 μg/mL) for EGCG-GNPs, RSV-GNPs, and FS-GNPs, 
respectively. Interestingly, at all tested concentrations, 
the reaction reaches steady state conditions after the first 
2 minutes (data not shown), suggesting that polyphenols on the 
surface of GNPs maintained a high antioxidant efficiency.
To elucidate in more detail the antioxidant activity differ-
ences detected for the obtained GNPs, the DPPH- and ABTS-
scavenging effects of EGCG, RSV, and FS raw materials at 
different concentrations were also evaluated.
As shown in Figure S3, the percentage of inhibition for 
DPPH of all polyphenols showed a good linearity at the tested 
concentrations. EGCG exhibited the highest antioxidant 
capacity with a percentage of DPPH inhibition that ranged 
from 9.5% (0.25 μg/mL) to 66% (2.5 μg/mL). At the same 
concentrations, values found for FS were decreased and ranged 
from 8.5% to 60%. On the other hand, RSV showed the low-
est antioxidant potential with comparable activity at higher 
concentrations (62.1% inhibition of DPPH at 20 μg/mL).
These findings are in agreement with previous reports and 
suggest that the DPPH antioxidant activity of polyphenolic 
compounds is closely associated with their chemical struc-
ture, such as the number and position of phenolic hydrogen, 
which influences the accessibility to the radical centre of 
DPPH•. Thus, the greater number of hydroxyl groups, 
especially O-dihydroxy group on B-ring of EGCG and FS 
with respect to RSV, are potentially able to quench more 
efficiently the free radicals by forming resonance-stabilized 
phenoxyl radicals.52
As concerns ABTS-scavenging activity (Figure S4), 
no significant differences were found for EGCG and RSV, 
with the percentage of inhibition of about 20% at lower 
concentration (0.5 μg/mL) and 65% at higher concentration 
(10 μg/mL). In contrast, the ABTS antioxidant activity of FS, 
at the same concentrations, decreased significantly, ranging 
from 16% to 53%.
The different behavior of polyphenols, and in particular 
of RSV, observed in DPPH and ABTS assays suggests 
that the reaction mechanisms involved in both methods are 
influenced by the chemical structure of the antioxidants, 
and that the two assay cations react by using different active 
chemical groups. In particular, in contrast to the oxidation of 
polyphenols by DPPH radicals that occur at B-ring, forming 
the corresponding O-quinone, or even at the C-2 position of 
the C-ring, the oxidation of polyphenols by ABTS radical 
cations occurs at the A-ring.53
Additionally, no significant DPPH and ABTS antioxidant 
activities were detected by using as control the nonfunctional-
ized GNPs at the same concentration of polyphenols-capped 
GNPs, thus confirming that radical-scavenging activities are 
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Figure 7 antioxidant activities of egcg-gNPs, rsV-gNPs, and Fs-gNPs at various concentrations assessed by percentage inhibition of DPPh (A) and aBTs (B) radicals.
Notes: gNP concentration expressed in μg/ml. egcg-gNPs, rsV-gNPs, and Fs-gNPs indicate polyphenol-capped nanogold.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ABTS, 2,2′-azinobis 
(3-ethylbenzothiazoline-6-sulfonic acid).




single-step green synthesis and characterization of gNPs
correlations between polyphenol 
content and antioxidant activity
The correlation coefficients (R2) were used to evaluate the 
correlation between each polyphenol content in GNPs and 
the methods used to determine their antioxidant capacity. 
As reported in Figure S5, the R2 values between DPPH and 
polyphenolic content were 0.9654, 0.9578, and 0.9944 for 
EGCG-GNPs, RSV-GNPs, and FS-GNPs, respectively. High 
correlation was also demonstrated between ABTS and poly-
phenolic content (R2=0.9944, 0.9923, and 0.9961 for EGCG-
GNPs, RSV-GNPs, and FS-GNPs, respectively).
These results suggest that the higher DPPH and ABTS 
antioxidant activities are correlated to the high EGCG, RSV, 
and FS content in GNPs. The R2 values for correlations 
between DPPH and ABTS assays were R2=0.9335, 0.9374, 
and 0.9843 for EGCG-GNPs, RSV-GNPs, and FS-GNPs, 
respectively (Figure S6).
antiproliferative activity and apoptosis 
activation in sh-sY5Y-cFP-DeVD-YFP cells
Several polyphenols have shown remarkable cancer-preventive 
and some cancer-therapeutic effects, partially due to their 
ability to induce apoptosis in cancer cells without affecting 
normal cells.
In this scenario, growth-suppressive effect on cell pro-
liferation demonstrated by polyphenols such as EGCG is 
mediated through programmed cell death or apoptosis by 
interfering with many cellular processes, including nuclear 
condensation, caspase-3 activation, and poly-ADP ribose 
polymerase cleavage, as well as eliciting the production of 
intracellular reactive oxygen species.54 The essential role of 
caspases (in particular, the key caspase-3 protein) in EGCG-
mediated inhibition of NF-kB and its subsequent apoptosis 
has also been demonstrated.55
To assess whether the engineered GNPs may alter cell 
proliferation and induce apoptosis, we took advantage of the 
neuronal SH-SY5Y cells stably expressing CFP-DEVD-YFP 
reporter.56 In this reporter the sequence coding for CFP (CFP: 
GFP with mutations Y66W, F64L, S65T, N146I, M153T, 
and V163A) is fused to the one coding for YPF (YFP: a 
particular GFP variant called Venus with mutations F64L, 
M153T, V163A, and S175G) via the aminoacidic sequence 
DEVD, which is the substrate for active caspase-3. Different 
stable cell lines were generated and characterized for the first 
time. Figure 8 shows the SH-SY5Y stable cell line used in the 
following experiments. The expression levels of CFP-DEVD-
YFP were evaluated by Western blot (Figure 8A) and immu-
nofluorescence (Figure 8B) experiments after induction of 
apoptosis by staurosporine treatment. As shown in Figure 8A, 
treatment with staurosporine determined the cleavage of 
DEVD target sequence and the resulting separation of two 
fluorescent proteins, indicating the activation of caspase-3.
Next, SH-SY5Y-CFP-DEVD-YFP cells were treated 
for 72 hours with EGCG-GNPs at different concentrations 
and cell viability was measured by MTS assay (Figure 8C). 
At the end of 72 hours of exposure, EGCG-GNPs decreased 
cell viability approximately in a dose-dependent manner, 
displaying an overlapping behavior with that of free EGCG. 
More specifically, both EGGC-GNPs and free EGCG exhib-
ited similar cytotoxicity profiles, showing a dose-dependent 
antiproliferative effect and inhibition values in the overall 
cell growth. With respect to control, at 1 μg/mL concen-
tration, EGCG-GNPs determined a growth inhibition of 
SH-SY5Y-CFP-DEVD-YFP cells of ~10%, similarly to an 
equivalent amount of free EGCG (ie, cells resulted in being 
exposed to equimolar amounts of free and capped EGCG). 
At 5 μg/mL, 10 μg/mL, and 25 μg/mL concentration 
exposure, tested EGCG-GNPs showed a reduction of cell 
viability of about 20%–30%, and, finally, treatment of SH-
SY5Y-CFP-DEVD-YFP cells with 50 μg/mL of EGCG-
GNPs proved the highest cytotoxicity, showing a cell growth 
inhibition of ~40% (Figure 8C).
Moreover, treatment of cells with EGCG-GNPs (and free 
ECGG) shared increased CFP-DEVD-YFP reporter cleavage 
(Figure 8D) due to caspase-3 activation, thus supporting an 
apoptotic mechanism of action.
In summary, EGCG-GNPs induce a dose-dependent 
reduction on cell viability that is likely to involve the activa-
tion of the apoptotic pathways.
Of course, to evaluate whether these activities may have an 
in vivo relevance when providing a reasonable dose of these 
NPs, further studies are in progress to explore a large panel of 
more responsive tumor cells. However, for comparative pur-
poses, in a previous in vivo study on polymeric NP-mediated 
delivery of bioactive catechins administered at concentrations 
ranging 5–20 μg/mouse, the polyphenols loading of NPs 
resulted in 3.38% and 5.76% of the polymer weight, similar to 
the concentration of polyphenols found in our prototypes.57
Conclusion
In this work, green synthesis of GNPs using natural polyphe-
nols EGCG, RSV, and FS was successfully investigated and 
proposed as a simple, reproducible, low-cost, and nontoxic 
method. Stable nanogolds were uniformly generated and fully 
characterized for their physicochemical properties. Overall, 
enhanced antioxidant properties were detected for all three 





prototypes, and this correlates well with the high EGCG, 
RSV, and FS content in GNPs. However, some differences 
in free radical-scavenging action between the three nano-
systems have been observed, due to their peculiar chemical 
structure. Moreover, a high degree of correlation among the 
antioxidant activities measured by DPPH and ABTS assays 
has been found in these polyphenol-capped GNPs. Our data 
on the antiproliferative activity of EGCG-GNPs in a neu-
roblastoma cell model demonstrated that these constructs 
induce a concentration-dependent reduction on cell viability 
by involving the activation of the apoptotic pathways. More-
over, the effectiveness of EGCG in terms of antiproliferative 
efficacy can be retained in EGCG-capped GNPs and supports 
the antioxidant capacity of these polyphenols and their ability 
to catalyze the decomposition/scavenging of free radicals.
These results would make these stable polyphenol-capped 
gold nanoprototypes suitable as functional and promising 
 candidates for the treatment of disorders associated with oxida-
tive stress, and extensive preclinical studies are warranted.
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Figure 8 effect of egcg-gNPs on cFP-DeVD-YFP reporter gene. (A) sh-sY5Y-derived cells expressing cFP-DeVD-YFP reporter gene were left untreated (-) or treated 
(+) for 2 hours with 1 μM staurosporine to induce caspase-3 activation. cell lysates were subjected to reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis. 
The anti-gFP antibody was used to visualize cFP-DeVD-YFP reporter and anti-β-actin serves as control for equal loading of samples. (B) Autofluorescence analysis of cells 
as in (A). (C) effect egcg-gNPs at 1, 5, 10, 25, and 50 μg/ml on sh-sY5Y-cFP-DeVD-YFP cells. (D) Western blots on protein extracts from cells treated as in (C) were 
performed using anti-gFP antibody and anti-β-actin as controls for equal egcg loading of samples (egcg-gNPs concentration =10 and 50 μg/ml).
Notes: results for MTs assays are the means ± seM of three experiments performed in triplicate. concentration of free egcg and egcg capped in gNPs is the same.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; GNPs, gold nanoparticles; GFP, green fluorescent protein; MTS, 3(4,5-dimethylthiazol-2yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2h-tetrazolium; seM, standard error of the mean.
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EGCG-GNPs RSV-GNPs FS-GNPs
Figure S1 Photograph of haucl4 solution (yellow solution) and colloidal egcg-gNPs (left), rsV-gNPs (middle), and Fs-gNPs (right).
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Figure S2 calibration curves of pure (A) egcg, (B) rsV, and (C) Fs used for the determination of polyphenol content.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin.
Supplementary materials
Figures S1–S6 report details on photographs of colloidal 
EGCG-GNPs, calibration curves, and antioxidant activity of 
pure EGCG, RSV, and FS at various concentrations assessed 
by percentage inhibition of DPPH and ABTS, as well as cor-
relation between radical-scavenging capacity assays (DPPH 
and ABTS) and correlation between DPPH and ABTS assays 
of nanogolds.





Figure S3 antioxidant activity of (A) egcg, (B) rsV, and (C) Fs raw materials at 
various concentrations assessed by percentage inhibition of DPPh.








































































Figure S4 antioxidant activity of (A) egcg, (B) rsV, and (C) Fs raw materials at 
various concentrations assessed by percentage inhibition of aBTs.
Abbreviations: EGCG, epigallocatechin-3-gallate; RSV, resveratrol; FS, fisetin; 
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single-step green synthesis and characterization of gNPs
Figure S5 correlation between radical-scavenging capacity assays (DPPh and 
aBTs) of egcg-gNPs, rsV-gNPs, and Fs-gNPs and (A) egcg, (B) rsV, and 
(C) Fs content (%, w/w).
Abbreviations: DPPh, 2,2-diphenyl-1-picrylhydrazyl; aBTs, 2,2′-azinobis 
(3-ethylbenzothiazoline-6-sulfonic acid) cation; egcg, epigallocatechin-3-gallate; 
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FS content (%, w/w)
Figure S6 correlation between DPPh and aBTs assays of (A) egcg-gNPs, 
(B) rsV-gNPs, and (C) Fs-gNPs.
Abbreviations: DPPh, 2,2-diphenyl-1-picrylhydrazyl; aBTs, 2,2′-azinobis 
(3-ethylbenzothiazoline-6-sulfonic acid) cation; egcg, epigallocatechin-3-gallate; 
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